<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="371022">
  <stage>Registered</stage>
  <submitdate>4/07/2016</submitdate>
  <approvaldate>20/07/2016</approvaldate>
  <actrnumber>ACTRN12616000957493</actrnumber>
  <trial_identification>
    <studytitle>Effect of ondansetron on the duration of caudal block with bupivacaine on children who undergoing infraumbilical surgery</studytitle>
    <scientifictitle>Effect of intravenously administered ondansetron on the duration and level of caudal block on pediatric patients whom ondergoing infraumbilical surgery </scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>Nil known</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>infraumbilical pediatric surgery</healthcondition>
    <conditioncode>
      <conditioncode1>Anaesthesiology</conditioncode1>
      <conditioncode2>Pain management</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>intravenous 0.1 mg/kg ondansetron in 30 seconds will given pediatric patients whom undergo infraumbilical surgery before immediately prior to caudal block. Caudal block will performed regardless of enrolment in this trial.</interventions>
    <comparator>Control treatment is intravenous normal saline at the same volume.</comparator>
    <control>Placebo</control>
    <interventioncode>Treatment: Drugs</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>caudal block duration time of analgesic effect will measured with faces pain scale </outcome>
      <timepoint>postoperative 24 hour (1 time for every hour)</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>caudal block sensorial level will tested with pin prick test.</outcome>
      <timepoint>postoperative 8 hours ( 1 time for each hour)</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>infraumbilical pediatric surgery patients and patients will be applied caudal block as part of the procedure
ASA ( American society of Anesthesiologists)physical status 1-2</inclusivecriteria>
    <inclusiveminage>4</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>10</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>patients who dont want to participate
contrindication for caudal block application
BMI&gt; 30 kg/m2
known allergic reactions to study drugs ( ondansetron, bupivacaine)
has neuorological or neuromuscular disease</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>central randomisation by computer</concealment>
    <sequence />
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1>False</masking1>
    <masking2>False</masking2>
    <masking3>True</masking3>
    <masking4>False</masking4>
    <patientregistry>False</patientregistry>
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase />
    <anticipatedstartdate />
    <actualstartdate>10/06/2016</actualstartdate>
    <anticipatedenddate>30/10/2016</anticipatedenddate>
    <actualenddate />
    <samplesize>66</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Recruiting</recruitmentstatus>
    <anticipatedlastvisitdate />
    <actuallastvisitdate />
    <dataanalysis />
    <withdrawnreason />
    <withdrawnreasonother />
    <recruitmentcountry>,Outside</recruitmentcountry>
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Turkey</country>
      <state>Konya</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>Baskent University</primarysponsorname>
    <primarysponsoraddress>Baglica Kampusu Eskisehir Yolu 20. km Baglica
06810 ANKARA</primarysponsoraddress>
    <primarysponsorcountry>Turkey</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>Baskent University</fundingname>
      <fundingaddress>Baglica Kampusu Eskisehir Yolu 20. km Baglica
06810 ANKARA</fundingaddress>
      <fundingcountry>Turkey</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>Caudal epidural block is usually performing for pediatric patients whom underwent infraumbilical surgery. for postoperative analgesia. There are some publications showed that 5 HT-3 antagonist drugs like ondansetron, rapids sensorial block regression of neuroaxial anesthesia. We want to evaluate this effect on caudal block on pediatric patients. 
We include 4-10 years old ASA 1 or 2 patients who will undergo infraumbilical surgery. we will exclude if patients BMI is over 30 kg/m2, have neurological or neuromuscular disease, allergy to sudy drugs, have contrindication for caudal block.
After routine monitorisation of patients and standart anesthetic induction for general anesthesia, we  divide patients into two groups . We  give 0.1 mg/kg ondansetron intravnously during seconds to Group Ondansetron and give same volume of serum physiologic for Group Control patients. After than we will perform caudal block with 1 ml/kg %0.025 bupivacaine at left decubitis position. After operation we will evaluate patients pain level with faces pain scale for 24 hours/ 1 time per hour and sensory level for 8 hours/ 1 time per hour.
we will evaluate these findings and want to determine if there is a significant effect of ondansetron administration on the analgesic duration or sensorial level of caudal block.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Baskent University Clinical Researches Ethical Committee</ethicname>
      <ethicaddress>Taskent Caddesi 77. Sokak No:11 06490 Bahcelievler Cankaya Ankara</ethicaddress>
      <ethicapprovaldate>29/04/2016</ethicapprovaldate>
      <hrec>KA 16/165</hrec>
      <ethicsubmitdate>2/02/2016</ethicsubmitdate>
      <ethiccountry>Turkey</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address>Baskent University,Hocacihan Mah. Saray Cad. No: 1 Selcuklu Postal Code: 42080 </address>
      <phone>+903322570606</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Principal Investigator</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address> Baskent University Konya Research Center Anesthesiology Department, 
Professional Address: Hocacihan Mah. Saray Cad. No: 1 Selcuklu/ Konya Postal Code: 42080 </address>
      <phone>+903322570606</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title>Mr</title>
      <name>Huseyin Ulas Pinar</name>
      <address>Baskent University Konya Research Center Anesthesiology Department, 
Professional Address: Hocacihan Mah. Saray Cad. No: 1 Selcuklu/ Konya Postal Code: 42080</address>
      <phone>+903322570606</phone>
      <fax>+903322570637</fax>
      <email>huseyinpinar2002@yahoo.com</email>
      <country>Turkey</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
  </contacts>
</ANZCTR_Trial>